ketoconazole has been researched along with Intestinal Diseases in 1 studies
1-acetyl-4-(4-{[2-(2,4-dichlorophenyl)-2-(1H-imidazol-1-ylmethyl)-1,3-dioxolan-4-yl]methoxy}phenyl)piperazine : A dioxolane that is 1,3-dioxolane which is substituted at positions 2, 2, and 4 by imidazol-1-ylmethyl, 2,4-dichlorophenyl, and [para-(4-acetylpiperazin-1-yl)phenoxy]methyl groups, respectively.
Intestinal Diseases: Pathological processes in any segment of the INTESTINE from DUODENUM to RECTUM.
| Excerpt | Relevance | Reference |
|---|---|---|
| " In a 10-day dosage regimen, UK-49,858 was far more active than ketoconazole against systemic infections with C." | 1.27 | Efficacy of UK-49,858 (fluconazole) against Candida albicans experimental infections in mice. ( Andrews, RJ; Brammer, KW; Marriott, MS; Richardson, K; Troke, PF, 1985) |
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 1 (100.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Troke, PF | 1 |
| Andrews, RJ | 1 |
| Brammer, KW | 1 |
| Marriott, MS | 1 |
| Richardson, K | 1 |
1 other study available for ketoconazole and Intestinal Diseases
| Article | Year |
|---|---|
Efficacy of UK-49,858 (fluconazole) against Candida albicans experimental infections in mice.
Topics: Amphotericin B; Animals; Antifungal Agents; Candidiasis; Female; Fluconazole; Immune Tolerance; Inte | 1985 |